The dark side of angiotensin II: Direct dynamic regulation of the glomerular filtration barrier permeability to macromolecules

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 6, 2012, Pages

  Palm, Fredrik ^a,b,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; EDITORIAL; GLOMERULAR FILTRATION BARRIER; HYPERTENSION; MACROMOLECULE; MOLECULAR BIOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; SIGNAL TRANSDUCTION;

EID: 84866391548     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00358.2012     Document Type: Editorial

References (6)

1. Axelsson J, Rippe A, Oberg CM, Rippe B. Rapid, dynamic changes in glomerular permeability to macromolecules during systemic angiotensin II (ANG II) infusion in rats. Am J Physiol Renal Physiol (First published June 20, 2012). doi:10.1152/ajprenal.00153.2012.
2. Bohrer MP, Deen WM, Robertson CR, Brenner BM. Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol Renal Fluid Electrolyte Physiol 233: F13-F21, 1977.
3. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001.
4. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol Regul Integr Comp Physiol 250: R960-R972, 1986.
5. Harris PJ, Navar LG. Tubular transport responses to angiotensin. Am J Physiol Renal Fluid Electrolyte Physiol 248: F621-F630, 1985.
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329: 1456-1462, 1993.